PGIM India Multi Cap Fund
The scheme seek to generate long term capital appreciation by investing in a portfolio of equity and equity related securities across large cap, mid cap and small cap stocks.
Growthvine rating: 1/5 — ranked #34 of 34 in category.
Fund basics
| Category | Equity: Multi Cap |
|---|
| NAV | ₹10.25 (as of 2026-10-01) |
|---|
| AUM | ₹468 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Anandha Padmanabhan Anjeneyan |
|---|
| Exit load | 0.5% for redemption within 90 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −18.61% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 103.6% of NIFTY500 Multicap 50:25:25's upside and 87.8% of its downside.
Market cap allocation
| Large cap | 40.7% |
|---|
| Mid cap | 27.9% |
|---|
| Small cap | 31.4% |
|---|
Concentration
| Top 5 holdings | 15.3% |
|---|
| Top 10 holdings | 24.4% |
|---|
| Total holdings | 99 |
|---|
| Index overlap | 36.2% |
|---|
| Active share | 63.8% |
|---|
Top holdings
- ICICI Bank Ltd. — 4.8%
- HDFC Bank Ltd. — 3.7%
- Clearing Corporation of India Ltd. — 2.7%
- Reliance Industries Ltd — 2.4%
- TVS Motor Company Ltd. — 2.4%
- Bharti Airtel Ltd. — 2.0%
- CG Power and Industrial Solutions Limited — 2.0%
- Indo Mim Ltd — 1.9%
- Eternal Limited — 1.8%
- Sansera Engineering Limited — 1.7%
Top sectors
- Banking & Financial — 18.2%
- Automobile — 10.3%
- Pharma & Biotech — 7.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 3.3% | Q1 (Top) | #9 of 34 |
| 2025 | 3.9% | Q2 | #13 of 31 |